Dose dependent effect of APOE ε4 on behavioral symptoms in frontal lobe dementia
Dose dependent effect of APOE ε4 on behavioral symptoms in frontal lobe dementia
复制标题
DOI:
10.1016/j.neurobiolaging.2005.02.005
复制
发表时间:
2006-02-01
影响因子:
4.2
通讯作者:
De Deyn, PP
中科院分区:
文献类型:
--
作者:
Engelborghs, S;Dermaut, B;De Deyn, PP
To determine whether apolipoprotein alleles (APOE) influence behavioral and psychological signs and symptoms of dementia (BPSD), we initiated a prospective, longitudinal study. Patients with Alzheimer's disease (AD) (N = 186), frontotemporal dementia (FTD) (N=29), mixed dementia (MXD) (N= 28), dementia with Lewy bodies (DLB) (N= 11) and Parkinson's disease dementia (PDD) (N = 7) were included. Blood was collected for DNA extraction and APOE genotyping. Behavioral assessments were performed at baseline and semi-annually thereafter, using behavioral assessment scales (Middelheim frontality score, behavioral pathology in Alzheimer's disease rating scale (Behave-AD)).In FTD patients, we identified close dependent effects of APOE epsilon 4 on the Behave-AD total and cluster aggressiveness scores. APOE epsilon 2 was associated with a higher score on the Behave-AD cluster delusions in PDD/DLB patients. No APOE effects on frequency or severity of BPSD in AD and MXD Patients Were found.In Conclusion, APOE has disease-specific effects on BPSD in FTD and PDD/DLB patients, given the reported associations of APOE epsilon 4 with aggression (FTD) and of APOE epsilon 2 with delusions (PDD/DLB). (C) 2005 Elsevier Inc. All rights reserved.